Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Odonate

27/07/2021 14:58

* Odonate Therapeutics Inc  ODT.OQ  reported a quarterly
adjusted loss of 58 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 33 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Odonate Therapeutics Inc's reported EPS for the quarter was a
loss of 58 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Odonate Therapeutics Inc shares had risen by 0.3% this
quarter and lost 81.8% so far this year.
* The company reported a quarterly loss of $22.02 million.
* Wall Street's median 12-month price target for Odonate
Therapeutics Inc is $4.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated July 27 at 01:58 p.m.  ​All
figures in US dollars unless otherwise stated